Gobbini, E. http://orcid.org/0000-0002-0555-5836
Chiari, R.
Pizzutillo, P.
Bordi, P.
Ghilardi, L.
Pilotto, S.
Osman, G.
Cappuzzo, F.
Cecere, F.
Riccardi, F.
Scotti, V.
Martelli, O.
Borra, G.
Maiello, E.
Rossi, A.
Graziano, P.
Gregorc, V.
Casartelli, C.
Sergi, C.
Del Conte, A.
Delmonte, A.
Bareggi, C.
Cortinovis, D.
Rizzo, P.
Tabbò, F.
Rossi, G.
Bria, E.
Galetta, D.
Tiseo, M.
Di Maio, M.
Novello, S.
Article History
Received: 9 August 2019
Accepted: 27 September 2019
First Online: 19 October 2019
Compliance with ethical standards
:
: Dr. Gobbini reports personal fees from Astrazeneca, grants and personal fees from Bristol-Myers Squibb, personal fees from Roche, personal fees from Merck Sharpe and Dohme, outside the submitted work; Dr. Pilotto reports personal fees from Astrazeneca, personal fees from Eli-Lilly, personal fees from Bristol Mayers Squibb, personal fees from Boehringer Ingelheim, personal fees from Roche, personal fees from Merck Sharpe and Dohme, personal fees from Istituto Gentili, outside the submitted work; Dr. Scotti reports personal fees from Roche, personal fees from Pfizer, outside the submitted work; Dr. Rossi reports personal fees from Roche, outside the submitted work; Dr. Cappuzzo reports personal fees from Roche, personal fees from Astrazeneca, personal fees from Brystol Myers Squibb, personal fees from Takeda, personal fees from Pfizer, personal fees from Eli-Lilly, personal fees from Merck Sharpe and Dohme, outside the submitted work; Dr. Di Maio reports personal fees from Brystol Myers Squibb, personal fees from Merck Sharp and Dohme, personal fees from Roche, personal fees from Astrazeneca, personal fees from Janssen, personal fees from Takeda, personal fees from Pfizer, outside the submitted work; Dr. Tiseo reports personal fees from Astrazeneca, personal fees from Brystol Myers Squibb, personal fees from Merck Sharpe and Dohme, personal fees from Boehringer Ingelheim, from Takeda, outside the submitted work; Dr. Novello reports personal fees from Astrazeneca, personal fees from Boheringer Ingelheim, personal fees from Brystol Myers Squibb, personal fees from Celgene, personal fees from Eli-Lilly, personal fees from Abbvie, personal fees from Merck Sharpe and Dohme, personal fees from Takeda, personal fees from Pfizer, personal fees from Roche, outside the submitted work.
: All procedures performed in this retrospective study involving human participants were in accordance with the ethical standards of the oncologic centers involved. Notably, this study (protocol n° 11/663) was approved by the central institutional review board of San Luigi Hospital in Orbassano (reference n° 91/2014) and the decision was transmitted to all the other oncologic centers involved.
: Informed consent was obtained from all individual participants included in the study for retrieving data from hospital medical record systems. Anonymized data were thus collected at the San Luigi Hospital. This protocol did not modify patient’s clinical management.